Ico Therapeutics, Inc. (ICOTF) - OTCQX
Company Description
iCo Therapeutics in-licenses and redefines existing drug candidates or generics by employing reformulation and delivery technologies for new or expanded use indications. The Company holds worldwide rights to an oral drug delivery platform, with Oral Amphotericin B (Amp B) as the initial platform... More
Sector: Financial
Industry: Diversified Investments
Country: Canada